COVID-19患者肺闪烁显像诊断肺栓塞:多中心研究
该多中心研究基于法国12个核医学科2020年3月至2021年4月的145例COVID-19疑似肺栓塞患者的V/Q SPECT/CT回顾性分析,评估通气显像的必要性。仅用灌注SPECT、灌注SPECT/CT或V/P SPECT/CT可分别排除27例(19%)、55例(38%)和45例(31%)患者的PE,V/P SPECT/CT阳性18例(12%),其中12例(67%)为低负荷PE(≤10%)。结论认为仅57%患者无需通气显像即可排除PE,31%患者需通气显像才能排除PE,总体PE患病率低(12%)。
要点
- 仅57%的COVID-19疑似PE患者无需通气显像即可自信排除PE
- 31%患者需加做通气显像才能排除PE
- V/P SPECT/CT阳性率12%,其中67%为低负荷PE(≤10%)
核心结论
- 在该COVID-19患者人群中,仅57%可无需通气显像自信排除PE,31%需通气显像才能排除PE。
- 总体PE患病率低(12%),V/P SPECT/CT阳性者中67%为低负荷PE(≤10%)。
研究设计与样本
- 法国核医学学会协作建立国家登记数据库,收集12个核医学科2020年3月至2021年4月的肺扫描。
- 回顾性分析145例COVID-19疑似PE患者的V/Q SPECT/CT,两名医师在不知临床信息下依次阅灌注SPECT、灌注SPECT/CT和V/P SPECT/CT。
- 所有科室均使用个人防护装备和专用清洁程序。
主要发现
- 仅用灌注SPECT可排除PE者27例(19%)。
- 仅用灌注SPECT/CT可排除PE者55例(38%)。
- 需V/P SPECT/CT才能排除PE者45例(31%)。
- V/P SPECT/CT阳性(按EANM标准的不匹配缺损提示PE)18例(12%),其中12例(67%)为低负荷PE(≤10%)。
关键数值与推荐
- 按欧洲核医学协会(EANM)标准,V/P SPECT/CT显示不匹配缺损提示PE。
- PE负荷≤10%定义为低负荷PE。
临床怎么用
- 在COVID-19疑似PE患者中,可先尝试仅用灌注SPECT或灌注SPECT/CT排除PE以减少通气操作带来的污染风险。
- 若灌注显像不能排除PE,需加做通气显像以自信排除PE。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In patients with novel coronavirus disease 2019 (COVID-19) referred for lung scintigraphy because of suspected pulmonary embolism (PE), there has been an ongoing debate within the nuclear medicine community as to whether and when the ventilation imaging should be performed. Indeed, whereas PE diagnosis typically relies on the recognition of ventilation-perfusion (V/P) mismatched defects, the ventilation procedure potentially increases the risk of contamination to health-care workers. The primary aim of this study was to assess the role of ventilation imaging when lung scintigraphy is performed because of suspected PE in COVID-19 patients. The secondary aim was to describe practices and imaging findings in this specific population. Methods: A national registry was created in collaboration with the French Society of Nuclear Medicine to collect lung scans performed on COVID-19 patients for suspected PE. The practices of departments were assessed regarding imaging protocols and aerosol precautions. A retrospective review of V/P SPECT/CT scans was then conducted. Two physicians masked to clinical information reviewed each case by sequentially viewing perfusion SPECT, perfusion SPECT/CT, and V/P SPECT/CT images. The scans were classified into 1 of the 4 following categories: patients for whom PE could reasonably be excluded on the basis of perfusion SPECT only, perfusion SPECT/CT, or V/P SPECT/CT and patients with mismatched defects suggestive of PE according to the European Association of Nuclear Medicine criteria. Results: Data from 12 French nuclear medicine departments were collected. Lung scans were performed between March 2020 and April 2021. Personal protective equipment and dedicated cleaning procedures were used in all departments. Of the 145 V/Q SPECT/CT scans included in the central review, PE could be excluded using only perfusion SPECT, perfusion SPECT/CT, or V/P SPECT/CT in 27 (19%), 55 (38%), and 45 (31%) patients, respectively. V/P SPECT/CT was positive for PE in 18 (12%) patients, including 12 (67%) with a low burden of PE (≤10%). Conclusion: In this population of COVID-19 patients assessed with lung scintigraphy, PE could confidently be excluded without the ventilation imaging in only 57% of patients. Ventilation imaging was required to confidently rule out PE in 31% of patients. Overall, the prevalence of PE was low (12%).
引用
- Roux PL, Bonnefoy PB, Bahloul A, et al. Lung Scintigraphy for Pulmonary Embolism Diagnosis in COVID-19 Patients: A Multicenter Study. J Nucl Med. 2021. PMID: 34649944. doi:10.2967/jnumed.121.262955
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。